Letrozole 2.5mg tablets are primarily used in the treatment of hormone-receptor-positive breast cancer. The specific protocol depends heavily on the patient’s individual circumstances, including the stage of cancer and overall health.
Breast Cancer Treatment
This dosage is often part of adjuvant therapy, following surgery or radiation, aiming to prevent cancer recurrence. It’s also used in neoadjuvant settings, before surgery, to shrink tumors. In advanced breast cancer, it can be a treatment option for hormone-receptor-positive disease that has progressed after tamoxifen or other hormonal therapies.
- Adjuvant Therapy: Typically administered for 5 years post-surgery. Your oncologist will tailor the duration based on your risk profile. Neoadjuvant Therapy: Used pre-operatively to reduce tumor size, improving surgical outcomes. The duration varies greatly depending on tumor response. Advanced Breast Cancer: Used as a second-line or later-line hormonal treatment. Treatment continues until disease progression or unacceptable side effects occur.
Infertility Treatment
In certain situations, a lower dosage of Letrozole, including 2.5mg, might be used off-label to aid in fertility treatment for women experiencing ovulation issues. This is a specialized application, however.
This usage requires careful monitoring by a reproductive endocrinologist. The specific protocol will vary based on individual responses and other fertility factors. Dosage adjustments are frequent, based on blood tests and ultrasound scans monitoring follicle development. This is Not a first-line treatment for infertility. Consult a specialist before considering this option.
Important Considerations
Remember, this information provides a general overview. Your physician will develop a personalized treatment plan based on your unique medical history, cancer type, and other relevant factors. Always discuss potential side effects and treatment alternatives with your healthcare professional. Regular monitoring is crucial during Letrozole therapy.
